An all-encompassing solution may have been found.
By Josh Conway – Lifespan.io
Researchers publishing in Nature Biotechnology have demonstrated a method of protecting mass-produced stem cells from the immune system, with strongly positive results in two different animal models.
Fake ID for the immune system
While it would be ideal to create stem cells from each person’s existing cells to replace that particular person’s needs and losses, this is still expensive, difficult, and time-consuming. Therefore, there is a great unmet medical need for readily available, off-the-shelf stem cell therapies, both within and outside the context of aging. For example, mass-produced, insulin-producing beta cells could potentially be an effective treatment for diabetes [1].
